A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia

NCT01678924 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuralgia, Postherpetic

Interventions

DRUG: AGN-214868
DRUG: AGN-214868 Placebo (Vehicle)

Sponsor

Allergan